Biotek-snakken — December 2021
-
IOBT i Melanoma (har fået BTD fra FDA): https://endpts.com/ido-on-the-rebound-danish-outfit-io-biotech-hopes-so-with-oversubscribed-series-b-one-month-after-btd-in-melanoma/
-
-
Har Saniona fået klø nok nu? Nede med 50% i år, men nu begynder ledelsen i det mindste at købe op
Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att styrelsens ordförande, VD och andra ledamöter i styrelsen och ledningsgruppen har förvärvat -
Will Adagio's COVID Antibody Therapy Be Too Late to the Party? https://www.proinvestor.com/investornyt/744996/will-adagios-covid-antibody-therapy-be-too-late-to-the-party
-
Bolt får en på tuden
-
-
Ser da også lidt tyndt ud på overfladen 1 PR 12 SD på 40n. Ser ud som om der er muligheder i Colorectal. side 12+20 i slide. Absolut ingen/lille virkning i GEA, så måske Zyme har ret i at deres tal er super gode. https://investors.boltbio.com/static-files/76e91664-ddf5-4d7f-814e-49821756b540
-
He rkommer lige et link til den seneste melding: https://via.ritzau.dk/ir-files/13559605/4520/5869/20211206 -ViroGates Company ann. 23.pdf
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind